Authors:
Kirby, RS
Andersen, M
Gratzke, P
Dahlstrand, C
Hoye, K
Citation: Rs. Kirby et al., A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia, BJU INT, 87(3), 2001, pp. 192-200
Authors:
Eaton, JD
Perry, MJA
Todryk, SM
Mazucco, RA
Kirby, RS
Griffiths, JR
Dalgleish, AG
Citation: Jd. Eaton et al., Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques, GENE THER, 8(7), 2001, pp. 557-567
Citation: Rl. Pierucci et al., End-of-life care for neonates and infants: The experience and effects of apalliative care consultation service, PEDIATRICS, 108(3), 2001, pp. 653-660
Authors:
Jacobson, GF
Autry, AM
Kirby, RS
Liverman, EM
Motley, RU
Citation: Gf. Jacobson et al., A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy, AM J OBST G, 184(7), 2001, pp. 1352-1356
Citation: Rs. Kirby, Invited commentary: Using vital statistics databases for perinatal epidemiology: Does the quality go in before the name goes on?, AM J EPIDEM, 154(10), 2001, pp. 889-890
Authors:
McAllister, WJ
Absalom, MJ
Mir, K
Shivde, S
Anson, K
Kirby, RS
Lawrence, WT
Paterson, PJ
Watson, GM
Fowler, CG
Citation: Wj. Mcallister et al., Does endoscopic laser ablation of the prostate stand the test of time? Five-year results from a multicentre randomized controlled trial of endoscopiclaser ablation against transurethral resection of the prostate, BJU INT, 85(4), 2000, pp. 437-439
Citation: Rs. Kirby et Jl. Pool, Interpretation of the ALLHAT interim analysis and implications for the treatment of patients with BPH, PROSTATE C, 3(3), 2000, pp. 152-156
Authors:
Feneley, MR
Jan, H
Granowska, M
Mather, SJ
Ellison, D
Glass, J
Coptcoat, M
Kirby, RS
Ogden, C
Oliver, RTD
Badenoch, DF
Chinegwundoh, FI
Nargund, VH
Paris, AMI
Britton, KE
Citation: Mr. Feneley et al., Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer, PROSTATE C, 3(1), 2000, pp. 47-52
Citation: Rs. Kirby, Analytical resources for assessment of clinical genetics services in public health: Current status and future prospects, TERATOLOGY, 61(1-2), 2000, pp. 9-16
Citation: Rs. Kirby, Lower urinary tract symptoms. Contribution of the prostate and the bladder. Short- and long-term effects of tamsulosin. Introduction, DRUGS TODAY, 36, 2000, pp. 1-2
Authors:
Gayther, SA
de Foy, EAF
Harrington, P
Pharoah, P
Dunsmuir, WD
Edwards, SM
Gillett, C
Ardern-Jones, A
Dearnaley, DP
Easton, DF
Ford, D
Shearer, RJ
Kirby, RS
Dowe, AL
Kelly, J
Stratton, MR
Ponder, BAJ
Barnes, D
Eeles, RA
Citation: Sa. Gayther et al., The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer, CANCER RES, 60(16), 2000, pp. 4513-4518
Citation: K. Hanlon-lundberg et Rs. Kirby, Association of ABO incompatibility with elevation of nucleated red blood cell counts in term neonates, AM J OBST G, 183(6), 2000, pp. 1532-1536